The European Commission has unveiled a long-awaited proposal to make Europe a “biotech powerhouse” by speeding up clinical trials, extending intellectual property protection and boosting

The Biosecure Act is slated to become law after the Senate on Wednesday passed a defense bill that includes the measure. It’s a development that

HHS Secretary Robert F. Kennedy Jr. added two conditions to a federal newborn screening list, reviving efforts that had been stalled under the Trump administration

The White House is preparing to unveil several new deals with large drugmakers on Friday as part of the administration’s “most favored nation” pricing push,

GSK has submitted a new label to the FDA for its drug leucovorin, telling regulators that it can treat a developmental disorder that’s been linked